L-carnitine: A potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure

American Journal of Physiology - Cell Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Vescovo, Giorgio ^a   Ravara, Barbara ^b   Gobbo, Valerio ^b   Sandri, Marco ^b   Angelini, Annalisa ^c   Barbera, Mila Della ^c   Dona, Massimo ^b   Peluso, Gianfranco ^d   Calvani, Menotti ^e   Mosconi, Luigi ^e   Libera, Luciano Dalla ^b  

^a City Hospital

^b CNR   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e Scientific Department   (Italy)

Author keywords

Caspases; Sphingosine; Staurosporine; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN; CARNITINE; CASPASE 3; CASPASE 9; CYTOKINE; DNA; GLUCOSE TRANSPORTER 4; MYOSIN HEAVY CHAIN; SPHINGOSINE; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID OXIDATION; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALIA;

EID: 17544399510     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00046.2002     Document Type: Article

References (37)

1. Acute and chronic effects of propionyl-L-carnitine on the hemodinamics, exercise capacity, and hormones in patients with congestive heart failure
2. L-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation
3. Cachexia in heart failure is bad for you
4. Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure
5. The role of sphingosine in inducing skeletal muscle apoptosis and atrophy in heart failure
6. Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNFα and sphingosine
7. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure
8. Plasma carnitine levels as a marker of impaired left ventricular functions
9. The propionyl-L-carnitine hypothesis: An alternative approach to treating heart failure
10. Lipid biochemistry: Functions of glycerolipids and sphingolipids in cellular signaling
11. Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers
12. Comparison of glucose transporter-containing vesicles from rat fat and muscle cells - Evidence for a unique endosomal compartment
13. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death
14. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
15. Abnormalities of skeletal muscle in patients with chronic heart failure
16. Determination of L-carnitine, acetyl-L-carnitine and propionylL-carnitine in human plasma by high-performance liquid chromatography after precolumn derivatization with 1-aminoanthracene
17. Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, and REINAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001
18. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure
19. Myocardial carnitine and palmitoyltransferase deficiencies in patient with severe heart failure
20. Apoptosis in multinucleated skeletal muscle myotubes
21. Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine
22. SPH mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte
23. Carnitine: An osmolyte that plays a metabolic role
24. Insulin-like effects of a physiologic concentration of carnitine on cardiac metabolism
25. The role of sphingolipids in the control of skeletal muscle function: A review
26. Apoptosis of skeletal muscle during development and disease
27. Metabolic adaptations in skeletal muscle overexpressing GLUT-4: Effects on muscle and physical activity
28. Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy
29. Improved exercise tolerance after losartan and enalapril in heart failure: Correlation with changes in skeletal muscle myosin heavy chain composition
30. Skeletal muscle myosin heavy chains in heart failure. Correlation between magnitude of the isozyme shift, exercise capacity and gas exchange measurements
31. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: Differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis
32. A new electrophoretic micromethod for assessing myosin heavy chain composition of skeletal muscle in chronic heart failure
33. Apoptosis in the skeletal muscle of patients with heart failure: Investigation of clinical and biochemical changes
34. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure
35. Predictors of exercise capacity in chronic heart failure
36. A skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals
37. Insulin-dependent protein trafficking in skeletal muscle cells